HIV	Human immunodeficiency virus
INSTIs	Integrase strand-transfer inhibitors
ART	Antiretroviral therapy
3′-PPT	3′polypurine tract
RAMs	Resistance-associated mutations
CRF	Circulating recombinant form
T	Threonine
A	Alanine
N	Asparagine
K	Lysine
E	Glutamic Acid
Q	Glutamine
M	Methionine
I	Isoleucine
S	Serine
R	Arginine
L	Leucine
D	Aspartic Acid
V	Valine
G	Glycine
C	Cysteine
DNA	Deoxyribonucleic acid
kDa	Kilodalton
Aa	Amino acids
AIDS	Acquired immunodeficiency syndrome
FDA	United States Food and Drug Administration
RAL	Raltegravir
EVG	Elvitegravir
DTG	Dolutegravir
WHO	World Health Organization
SSA	Sub-Saharan Africa
PLWH	People living with HIV
DRMs	Drug-resistance mutations
URF	Unique recombinant form
LTR	Long terminal repeats
UNMC	University of Nebraska Medical Center
ELISA	Enzyme-linked immunosorbent assay
CD4	cluster of differentiation 4
FACS	Fluorescence-Activated Cell Sorting
RT-PCR	Reverse transcription polymerase chain reaction
RNA	Ribonucleic acid
cDNA	complementary DNA
PCR	Polymerase chain reaction
NCBI	National Center for Biotechnology Information
FDR	False discovery rate